Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint...
Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors
About this item
Full title
Author / Creator
Kurimoto, Chiaki , Inaba, Hidefumi , Ariyasu, Hiroyuki , Iwakura, Hiroshi , Ueda, Yoko , Uraki, Shinsuke , Takeshima, Ken , Furukawa, Yasushi , Morita, Shuhei , Yamamoto, Yuki , Yamashita, Shimpei , Katsuda, Masahiro , Hayata, Atsushi , Akamatsu, Hiroaki , Jinnin, Masatoshi , Hara, Isao , Yamaue, Hiroki and Akamizu, Takashi
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Immune‐related adverse events (irAEs) are often seen during immune‐checkpoint inhibitor (ICI) treatment of various malignancies. Endocrine irAEs including thyroid dysfunctions are the most common irAEs, but their biomarkers remain unclear. In order to identify individuals who are susceptible to thyroid irAE for earlier diagnosis and appropriate fol...
Alternative Titles
Full title
Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7226278
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7226278
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/cas.14363
